Open | $39.390 |
Close | $39.350 |
Volume / Avg. | 579.841K / 463.842K |
Day Range | 38.860 - 39.900 |
52 Wk Range | 20.830 - 39.450 |
Market Cap | $1.258B |
P/E Ratio | 30.302 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 73 |
Short Interest | 26.3% |
Days to Cover | 24.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Collegium Pharmaceutical (NASDAQ: COLL) through any online brokerage.
Other companies in Collegium Pharmaceutical’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Collegium Pharmaceutical (NASDAQ: COLL) was reported by Truist Securities on Monday, February 26, 2024. The analyst firm set a price target for 40.00 expecting COLL to rise to within 12 months (a possible 1.65% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $39.35 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Collegium Pharmaceutical.
Collegium Pharmaceutical’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Collegium Pharmaceutical.
Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.